nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Mitoxantrone—lymphatic system cancer	0.212	0.475	CbGbCtD
Mannitol—ABCB1—Vincristine—lymphatic system cancer	0.146	0.327	CbGbCtD
Mannitol—ABCB1—Methotrexate—lymphatic system cancer	0.0883	0.198	CbGbCtD
Mannitol—Stomatitis—Fludarabine—lymphatic system cancer	0.00334	0.00603	CcSEcCtD
Mannitol—Phlebitis—Carmustine—lymphatic system cancer	0.0033	0.00596	CcSEcCtD
Mannitol—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00329	0.00593	CcSEcCtD
Mannitol—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00328	0.00591	CcSEcCtD
Mannitol—Diabetes mellitus—Carmustine—lymphatic system cancer	0.00327	0.00591	CcSEcCtD
Mannitol—Chills—Teniposide—lymphatic system cancer	0.00314	0.00567	CcSEcCtD
Mannitol—Polyuria—Vincristine—lymphatic system cancer	0.00309	0.00558	CcSEcCtD
Mannitol—Phlebitis—Mitoxantrone—lymphatic system cancer	0.00307	0.00554	CcSEcCtD
Mannitol—Pharyngitis—Fludarabine—lymphatic system cancer	0.00305	0.00551	CcSEcCtD
Mannitol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00293	0.00529	CcSEcCtD
Mannitol—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.00292	0.00527	CcSEcCtD
Mannitol—Hypoxia—Methotrexate—lymphatic system cancer	0.00286	0.00516	CcSEcCtD
Mannitol—Hyponatraemia—Carmustine—lymphatic system cancer	0.00286	0.00516	CcSEcCtD
Mannitol—Bronchospasm—Bleomycin—lymphatic system cancer	0.00277	0.005	CcSEcCtD
Mannitol—Chills—Fludarabine—lymphatic system cancer	0.00276	0.00498	CcSEcCtD
Mannitol—Hyponatraemia—Vincristine—lymphatic system cancer	0.00273	0.00492	CcSEcCtD
Mannitol—Pain in extremity—Vincristine—lymphatic system cancer	0.00272	0.0049	CcSEcCtD
Mannitol—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00271	0.00489	CcSEcCtD
Mannitol—Malnutrition—Fludarabine—lymphatic system cancer	0.00268	0.00483	CcSEcCtD
Mannitol—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.00266	0.00479	CcSEcCtD
Mannitol—Hypertension—Teniposide—lymphatic system cancer	0.00263	0.00475	CcSEcCtD
Mannitol—Chest pain—Teniposide—lymphatic system cancer	0.00259	0.00468	CcSEcCtD
Mannitol—Urinary retention—Vincristine—lymphatic system cancer	0.00258	0.00466	CcSEcCtD
Mannitol—Lung disorder—Methotrexate—lymphatic system cancer	0.00257	0.00463	CcSEcCtD
Mannitol—Dehydration—Vincristine—lymphatic system cancer	0.00253	0.00456	CcSEcCtD
Mannitol—Oedema—Teniposide—lymphatic system cancer	0.00249	0.00449	CcSEcCtD
Mannitol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00249	0.00449	CcSEcCtD
Mannitol—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00249	0.00448	CcSEcCtD
Mannitol—Infection—Teniposide—lymphatic system cancer	0.00247	0.00446	CcSEcCtD
Mannitol—Dehydration—Mitoxantrone—lymphatic system cancer	0.00246	0.00444	CcSEcCtD
Mannitol—Stomatitis—Bleomycin—lymphatic system cancer	0.00245	0.00442	CcSEcCtD
Mannitol—Tachycardia—Teniposide—lymphatic system cancer	0.00243	0.00438	CcSEcCtD
Mannitol—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00242	0.00436	CcSEcCtD
Mannitol—Malaise—Fludarabine—lymphatic system cancer	0.00242	0.00436	CcSEcCtD
Mannitol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00239	0.00431	CcSEcCtD
Mannitol—Cough—Fludarabine—lymphatic system cancer	0.00234	0.00422	CcSEcCtD
Mannitol—Hypotension—Teniposide—lymphatic system cancer	0.00232	0.00419	CcSEcCtD
Mannitol—Convulsion—Fludarabine—lymphatic system cancer	0.00232	0.00419	CcSEcCtD
Mannitol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00231	0.00417	CcSEcCtD
Mannitol—Arthralgia—Fludarabine—lymphatic system cancer	0.00228	0.00411	CcSEcCtD
Mannitol—Discomfort—Fludarabine—lymphatic system cancer	0.00225	0.00407	CcSEcCtD
Mannitol—Dyspnoea—Teniposide—lymphatic system cancer	0.00222	0.004	CcSEcCtD
Mannitol—Oedema—Fludarabine—lymphatic system cancer	0.00219	0.00394	CcSEcCtD
Mannitol—Infection—Fludarabine—lymphatic system cancer	0.00217	0.00392	CcSEcCtD
Mannitol—Decreased appetite—Teniposide—lymphatic system cancer	0.00216	0.0039	CcSEcCtD
Mannitol—Renal failure—Carmustine—lymphatic system cancer	0.00216	0.00389	CcSEcCtD
Mannitol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00215	0.00387	CcSEcCtD
Mannitol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00214	0.00387	CcSEcCtD
Mannitol—Stomatitis—Carmustine—lymphatic system cancer	0.00214	0.00386	CcSEcCtD
Mannitol—Rash—Mechlorethamine—lymphatic system cancer	0.00213	0.00384	CcSEcCtD
Mannitol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00213	0.00384	CcSEcCtD
Mannitol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00213	0.00383	CcSEcCtD
Mannitol—Extravasation—Methotrexate—lymphatic system cancer	0.00208	0.00376	CcSEcCtD
Mannitol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00205	0.0037	CcSEcCtD
Mannitol—Stomatitis—Vincristine—lymphatic system cancer	0.00204	0.00368	CcSEcCtD
Mannitol—Chills—Bleomycin—lymphatic system cancer	0.00202	0.00365	CcSEcCtD
Mannitol—Renal failure—Mitoxantrone—lymphatic system cancer	0.002	0.00362	CcSEcCtD
Mannitol—Nausea—Mechlorethamine—lymphatic system cancer	0.002	0.00362	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00199	0.00359	CcSEcCtD
Mannitol—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00199	0.00359	CcSEcCtD
Mannitol—Urticaria—Teniposide—lymphatic system cancer	0.00198	0.00357	CcSEcCtD
Mannitol—Body temperature increased—Teniposide—lymphatic system cancer	0.00197	0.00355	CcSEcCtD
Mannitol—Dyspnoea—Fludarabine—lymphatic system cancer	0.00195	0.00352	CcSEcCtD
Mannitol—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00194	0.00349	CcSEcCtD
Mannitol—Decreased appetite—Fludarabine—lymphatic system cancer	0.0019	0.00343	CcSEcCtD
Mannitol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00189	0.00341	CcSEcCtD
Mannitol—Fatigue—Fludarabine—lymphatic system cancer	0.00188	0.0034	CcSEcCtD
Mannitol—Pain—Fludarabine—lymphatic system cancer	0.00187	0.00337	CcSEcCtD
Mannitol—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00186	0.00335	CcSEcCtD
Mannitol—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00185	0.00333	CcSEcCtD
Mannitol—Urethral disorder—Vincristine—lymphatic system cancer	0.00184	0.00333	CcSEcCtD
Mannitol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00184	0.00331	CcSEcCtD
Mannitol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00183	0.00331	CcSEcCtD
Mannitol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00182	0.00329	CcSEcCtD
Mannitol—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00182	0.00328	CcSEcCtD
Mannitol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0018	0.00325	CcSEcCtD
Mannitol—Asthenia—Teniposide—lymphatic system cancer	0.00178	0.00322	CcSEcCtD
Mannitol—Malaise—Bleomycin—lymphatic system cancer	0.00177	0.0032	CcSEcCtD
Mannitol—Pruritus—Teniposide—lymphatic system cancer	0.00176	0.00318	CcSEcCtD
Mannitol—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00173	0.00313	CcSEcCtD
Mannitol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00173	0.00312	CcSEcCtD
Mannitol—Mental disorder—Carmustine—lymphatic system cancer	0.00173	0.00311	CcSEcCtD
Mannitol—Malnutrition—Carmustine—lymphatic system cancer	0.00171	0.00309	CcSEcCtD
Mannitol—Cough—Bleomycin—lymphatic system cancer	0.00171	0.00309	CcSEcCtD
Mannitol—Diarrhoea—Teniposide—lymphatic system cancer	0.0017	0.00307	CcSEcCtD
Mannitol—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00169	0.00306	CcSEcCtD
Mannitol—Chest pain—Bleomycin—lymphatic system cancer	0.00167	0.00302	CcSEcCtD
Mannitol—Back pain—Carmustine—lymphatic system cancer	0.00166	0.00299	CcSEcCtD
Mannitol—Discomfort—Bleomycin—lymphatic system cancer	0.00165	0.00298	CcSEcCtD
Mannitol—Mental disorder—Vincristine—lymphatic system cancer	0.00165	0.00297	CcSEcCtD
Mannitol—Chills—Mitoxantrone—lymphatic system cancer	0.00164	0.00296	CcSEcCtD
Mannitol—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00162	0.00292	CcSEcCtD
Mannitol—Vision blurred—Carmustine—lymphatic system cancer	0.00162	0.00292	CcSEcCtD
Mannitol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00161	0.00291	CcSEcCtD
Mannitol—Oedema—Bleomycin—lymphatic system cancer	0.0016	0.00289	CcSEcCtD
Mannitol—Infection—Bleomycin—lymphatic system cancer	0.00159	0.00287	CcSEcCtD
Mannitol—Back pain—Vincristine—lymphatic system cancer	0.00158	0.00286	CcSEcCtD
Mannitol—Vomiting—Teniposide—lymphatic system cancer	0.00158	0.00285	CcSEcCtD
Mannitol—Asthenia—Fludarabine—lymphatic system cancer	0.00157	0.00283	CcSEcCtD
Mannitol—Rash—Teniposide—lymphatic system cancer	0.00157	0.00283	CcSEcCtD
Mannitol—Dermatitis—Teniposide—lymphatic system cancer	0.00157	0.00283	CcSEcCtD
Mannitol—Headache—Teniposide—lymphatic system cancer	0.00156	0.00281	CcSEcCtD
Mannitol—Pruritus—Fludarabine—lymphatic system cancer	0.00155	0.00279	CcSEcCtD
Mannitol—Back pain—Mitoxantrone—lymphatic system cancer	0.00154	0.00278	CcSEcCtD
Mannitol—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00152	0.00275	CcSEcCtD
Mannitol—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00152	0.00274	CcSEcCtD
Mannitol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.0015	0.00271	CcSEcCtD
Mannitol—Polyuria—Methotrexate—lymphatic system cancer	0.0015	0.00271	CcSEcCtD
Mannitol—Hypotension—Bleomycin—lymphatic system cancer	0.0015	0.0027	CcSEcCtD
Mannitol—Diarrhoea—Fludarabine—lymphatic system cancer	0.0015	0.0027	CcSEcCtD
Mannitol—Convulsion—Carmustine—lymphatic system cancer	0.00149	0.00268	CcSEcCtD
Mannitol—Hypertension—Carmustine—lymphatic system cancer	0.00148	0.00267	CcSEcCtD
Mannitol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00148	0.00267	CcSEcCtD
Mannitol—Nausea—Teniposide—lymphatic system cancer	0.00148	0.00267	CcSEcCtD
Mannitol—Vertigo—Vincristine—lymphatic system cancer	0.00147	0.00265	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00146	0.00263	CcSEcCtD
Mannitol—Chest pain—Carmustine—lymphatic system cancer	0.00146	0.00263	CcSEcCtD
Mannitol—Malaise—Mitoxantrone—lymphatic system cancer	0.00144	0.00259	CcSEcCtD
Mannitol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00143	0.00258	CcSEcCtD
Mannitol—Convulsion—Vincristine—lymphatic system cancer	0.00142	0.00256	CcSEcCtD
Mannitol—Hypertension—Vincristine—lymphatic system cancer	0.00141	0.00255	CcSEcCtD
Mannitol—Oedema—Carmustine—lymphatic system cancer	0.0014	0.00252	CcSEcCtD
Mannitol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00139	0.00251	CcSEcCtD
Mannitol—Cough—Mitoxantrone—lymphatic system cancer	0.00139	0.00251	CcSEcCtD
Mannitol—Infection—Carmustine—lymphatic system cancer	0.00139	0.00251	CcSEcCtD
Mannitol—Vomiting—Fludarabine—lymphatic system cancer	0.00139	0.00251	CcSEcCtD
Mannitol—Convulsion—Mitoxantrone—lymphatic system cancer	0.00138	0.00249	CcSEcCtD
Mannitol—Rash—Fludarabine—lymphatic system cancer	0.00138	0.00249	CcSEcCtD
Mannitol—Dermatitis—Fludarabine—lymphatic system cancer	0.00138	0.00248	CcSEcCtD
Mannitol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00138	0.00248	CcSEcCtD
Mannitol—Pain—Bleomycin—lymphatic system cancer	0.00137	0.00247	CcSEcCtD
Mannitol—Headache—Fludarabine—lymphatic system cancer	0.00137	0.00247	CcSEcCtD
Mannitol—Tachycardia—Carmustine—lymphatic system cancer	0.00137	0.00246	CcSEcCtD
Mannitol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00136	0.00245	CcSEcCtD
Mannitol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00136	0.00245	CcSEcCtD
Mannitol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00134	0.00242	CcSEcCtD
Mannitol—Oedema—Vincristine—lymphatic system cancer	0.00134	0.00241	CcSEcCtD
Mannitol—Infection—Vincristine—lymphatic system cancer	0.00133	0.00239	CcSEcCtD
Mannitol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00132	0.00238	CcSEcCtD
Mannitol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00131	0.00236	CcSEcCtD
Mannitol—Hypotension—Carmustine—lymphatic system cancer	0.00131	0.00236	CcSEcCtD
Mannitol—Oedema—Mitoxantrone—lymphatic system cancer	0.0013	0.00235	CcSEcCtD
Mannitol—Nausea—Fludarabine—lymphatic system cancer	0.0013	0.00234	CcSEcCtD
Mannitol—Infection—Mitoxantrone—lymphatic system cancer	0.00129	0.00233	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00127	0.0023	CcSEcCtD
Mannitol—Urticaria—Bleomycin—lymphatic system cancer	0.00127	0.0023	CcSEcCtD
Mannitol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00127	0.00229	CcSEcCtD
Mannitol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00127	0.00229	CcSEcCtD
Mannitol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00126	0.00228	CcSEcCtD
Mannitol—Hypotension—Vincristine—lymphatic system cancer	0.00125	0.00225	CcSEcCtD
Mannitol—Dyspnoea—Carmustine—lymphatic system cancer	0.00125	0.00225	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00122	0.0022	CcSEcCtD
Mannitol—Decreased appetite—Carmustine—lymphatic system cancer	0.00122	0.00219	CcSEcCtD
Mannitol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00122	0.00219	CcSEcCtD
Mannitol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00121	0.00218	CcSEcCtD
Mannitol—Pain—Carmustine—lymphatic system cancer	0.0012	0.00216	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00118	0.00214	CcSEcCtD
Mannitol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00118	0.00213	CcSEcCtD
Mannitol—Decreased appetite—Vincristine—lymphatic system cancer	0.00116	0.00209	CcSEcCtD
Mannitol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00116	0.00209	CcSEcCtD
Mannitol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00115	0.00208	CcSEcCtD
Mannitol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00115	0.00208	CcSEcCtD
Mannitol—Fatigue—Vincristine—lymphatic system cancer	0.00115	0.00208	CcSEcCtD
Mannitol—Asthenia—Bleomycin—lymphatic system cancer	0.00115	0.00208	CcSEcCtD
Mannitol—Pain—Vincristine—lymphatic system cancer	0.00114	0.00206	CcSEcCtD
Mannitol—Pruritus—Bleomycin—lymphatic system cancer	0.00113	0.00205	CcSEcCtD
Mannitol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00113	0.00204	CcSEcCtD
Mannitol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00112	0.00202	CcSEcCtD
Mannitol—Pain—Mitoxantrone—lymphatic system cancer	0.00111	0.00201	CcSEcCtD
Mannitol—Body temperature increased—Carmustine—lymphatic system cancer	0.00111	0.002	CcSEcCtD
Mannitol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00107	0.00193	CcSEcCtD
Mannitol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00106	0.00191	CcSEcCtD
Mannitol—Body temperature increased—Vincristine—lymphatic system cancer	0.00106	0.00191	CcSEcCtD
Mannitol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00103	0.00186	CcSEcCtD
Mannitol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00103	0.00186	CcSEcCtD
Mannitol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00103	0.00186	CcSEcCtD
Mannitol—Vomiting—Bleomycin—lymphatic system cancer	0.00102	0.00184	CcSEcCtD
Mannitol—Infestation NOS—Methotrexate—lymphatic system cancer	0.00102	0.00183	CcSEcCtD
Mannitol—Infestation—Methotrexate—lymphatic system cancer	0.00102	0.00183	CcSEcCtD
Mannitol—Rash—Bleomycin—lymphatic system cancer	0.00101	0.00182	CcSEcCtD
Mannitol—Dermatitis—Bleomycin—lymphatic system cancer	0.00101	0.00182	CcSEcCtD
Mannitol—Asthenia—Carmustine—lymphatic system cancer	0.001	0.00181	CcSEcCtD
Mannitol—Renal failure—Methotrexate—lymphatic system cancer	0.000999	0.0018	CcSEcCtD
Mannitol—Stomatitis—Methotrexate—lymphatic system cancer	0.00099	0.00179	CcSEcCtD
Mannitol—Hypersensitivity—Vincristine—lymphatic system cancer	0.000984	0.00178	CcSEcCtD
Mannitol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000958	0.00173	CcSEcCtD
Mannitol—Asthenia—Vincristine—lymphatic system cancer	0.000958	0.00173	CcSEcCtD
Mannitol—Diarrhoea—Carmustine—lymphatic system cancer	0.000957	0.00173	CcSEcCtD
Mannitol—Nausea—Bleomycin—lymphatic system cancer	0.000952	0.00172	CcSEcCtD
Mannitol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000933	0.00168	CcSEcCtD
Mannitol—Dizziness—Carmustine—lymphatic system cancer	0.000925	0.00167	CcSEcCtD
Mannitol—Diarrhoea—Vincristine—lymphatic system cancer	0.000914	0.00165	CcSEcCtD
Mannitol—Pharyngitis—Methotrexate—lymphatic system cancer	0.000905	0.00163	CcSEcCtD
Mannitol—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000901	0.00163	CcSEcCtD
Mannitol—Urethral disorder—Methotrexate—lymphatic system cancer	0.000894	0.00161	CcSEcCtD
Mannitol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00089	0.00161	CcSEcCtD
Mannitol—Vomiting—Carmustine—lymphatic system cancer	0.000889	0.00161	CcSEcCtD
Mannitol—Dizziness—Vincristine—lymphatic system cancer	0.000883	0.00159	CcSEcCtD
Mannitol—Rash—Carmustine—lymphatic system cancer	0.000882	0.00159	CcSEcCtD
Mannitol—Dermatitis—Carmustine—lymphatic system cancer	0.000881	0.00159	CcSEcCtD
Mannitol—Headache—Carmustine—lymphatic system cancer	0.000876	0.00158	CcSEcCtD
Mannitol—Vomiting—Vincristine—lymphatic system cancer	0.000849	0.00153	CcSEcCtD
Mannitol—Rash—Vincristine—lymphatic system cancer	0.000842	0.00152	CcSEcCtD
Mannitol—Dermatitis—Vincristine—lymphatic system cancer	0.000841	0.00152	CcSEcCtD
Mannitol—Headache—Vincristine—lymphatic system cancer	0.000837	0.00151	CcSEcCtD
Mannitol—Nausea—Carmustine—lymphatic system cancer	0.000831	0.0015	CcSEcCtD
Mannitol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000827	0.00149	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000822	0.00148	CcSEcCtD
Mannitol—Rash—Mitoxantrone—lymphatic system cancer	0.00082	0.00148	CcSEcCtD
Mannitol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000819	0.00148	CcSEcCtD
Mannitol—Chills—Methotrexate—lymphatic system cancer	0.000818	0.00148	CcSEcCtD
Mannitol—Headache—Mitoxantrone—lymphatic system cancer	0.000815	0.00147	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—lymphatic system cancer	0.000799	0.00144	CcSEcCtD
Mannitol—Malnutrition—Methotrexate—lymphatic system cancer	0.000794	0.00143	CcSEcCtD
Mannitol—Nausea—Vincristine—lymphatic system cancer	0.000793	0.00143	CcSEcCtD
Mannitol—Nausea—Mitoxantrone—lymphatic system cancer	0.000773	0.00139	CcSEcCtD
Mannitol—Back pain—Methotrexate—lymphatic system cancer	0.000768	0.00139	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—lymphatic system cancer	0.000748	0.00135	CcSEcCtD
Mannitol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000737	0.00133	CcSEcCtD
Mannitol—Malaise—Methotrexate—lymphatic system cancer	0.000716	0.00129	CcSEcCtD
Mannitol—Vertigo—Methotrexate—lymphatic system cancer	0.000713	0.00129	CcSEcCtD
Mannitol—Cough—Methotrexate—lymphatic system cancer	0.000693	0.00125	CcSEcCtD
Mannitol—Convulsion—Methotrexate—lymphatic system cancer	0.000688	0.00124	CcSEcCtD
Mannitol—Arthralgia—Methotrexate—lymphatic system cancer	0.000676	0.00122	CcSEcCtD
Mannitol—Chest pain—Methotrexate—lymphatic system cancer	0.000676	0.00122	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000671	0.00121	CcSEcCtD
Mannitol—Discomfort—Methotrexate—lymphatic system cancer	0.000668	0.00121	CcSEcCtD
Mannitol—Infection—Methotrexate—lymphatic system cancer	0.000644	0.00116	CcSEcCtD
Mannitol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000635	0.00115	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—lymphatic system cancer	0.000629	0.00114	CcSEcCtD
Mannitol—Hypotension—Methotrexate—lymphatic system cancer	0.000606	0.00109	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00059	0.00107	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—lymphatic system cancer	0.000578	0.00104	CcSEcCtD
Mannitol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000563	0.00102	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000559	0.00101	CcSEcCtD
Mannitol—Fatigue—Methotrexate—lymphatic system cancer	0.000559	0.00101	CcSEcCtD
Mannitol—Pain—Methotrexate—lymphatic system cancer	0.000554	0.001	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000534	0.000964	CcSEcCtD
Mannitol—Urticaria—Methotrexate—lymphatic system cancer	0.000515	0.000929	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000512	0.000924	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000477	0.000862	CcSEcCtD
Mannitol—Asthenia—Methotrexate—lymphatic system cancer	0.000465	0.000839	CcSEcCtD
Mannitol—Pruritus—Methotrexate—lymphatic system cancer	0.000458	0.000827	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000443	0.0008	CcSEcCtD
Mannitol—Dizziness—Methotrexate—lymphatic system cancer	0.000429	0.000773	CcSEcCtD
Mannitol—Vomiting—Methotrexate—lymphatic system cancer	0.000412	0.000743	CcSEcCtD
Mannitol—Rash—Methotrexate—lymphatic system cancer	0.000409	0.000737	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—lymphatic system cancer	0.000408	0.000737	CcSEcCtD
Mannitol—Headache—Methotrexate—lymphatic system cancer	0.000406	0.000733	CcSEcCtD
Mannitol—Nausea—Methotrexate—lymphatic system cancer	0.000385	0.000695	CcSEcCtD
